Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty

Circulation Research

Volumn 80, Issue 3, 1997, Pages 418-426

  Wei, Geeveon Laura ^a   Krasinski, Kevin ^a   Kearney, Marianne ^a   Isner, Jeffrey M ^a   Walsh, Kenneth ^a   Andrés, Vicente ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

angioplasty; cell cycle control; restenosis

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0031043721     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.0000435858.35902.ea     Document Type: Article

References (56)

1. Owens GK, Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;236:242-250.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond). 1993;362:801-809.
4. Shi Y, Fard A, Galeo A, Hutchinson HG, Vermani P, Dodge GR, Hall DJ, Shaheen F, Zalewski A. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation. 1994;90:944-931.
5. Simons M, Edelman ER, DeKeyser J-L, Langer R, Rosenberg RD, Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (Lond). 1992;359:67-70.
6. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI, Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo in c-myc antisense oligodeoxynucleotides. J Clin Invest. 1994;93:820-828.
7. Abe J, Zhou W, Taguchi J, Takuwa N, Mtki K, Okaraki H, Kurokawa K, Kumadt M, Takuwa Y, Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery. Biochem Biophys Res Commun. 1994;198:16-24.
8. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ, Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA, 1993;90:8474-8478.
9. Morishita R, Gibbons GH, Ellison KE, Nakejtma M, von der Leyen H, Zbang L, Kaneda Y, Ogihara T, Dzau VJ. Intimal hyperpiasia after vascular injury is inhibited by antisense edk 2 kinase oligonucleotides, J Clin Invest. 1994;93:1458-1464.
10. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyelin BI and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene. 1994;149:13-19.
11. Chang MW, Barr E, Seltzer J, Jiang Y, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
12. Chang MW, Barr E, Lu MM, Barton K, Leiden JM, Adenovirusmediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty, J Clin Invest, 1995;96:2260-2268.
13. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ, Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimai hyperpiasia in vivo. J Clin Invest. 1993;91:1822-1829.
14. Nabel EG, Yang Z, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature (Lond). 1993;362:844-846.
15. Heichman KA, Roberts JM, Rules to replicate by. Cell. 1994;79:557-562.
16. King RW, Jackson PK, Kirschner MW, Mitosis in transition. Cell. 1994;79:563-571.
17. Morgan DO, Principles of CDK regulation, Nature (Lond). 1995;374:131-134.
18. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta. 1993;1155:63-78.
19. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 1994;79:547-550.
20. Grana X, Reddy EP, Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995;11:211-219.
21. Peeper DS, van der Eb AJ, Zantema A, The G1/S cell-cycle check-point in eukaryotic cells. Biochim Biophys Acta. 1994;1198:215-230.
22. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
23. Guadagno TM, Newport JW, Cdk2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinase activity. Cell. 1996;84:73-82.
24. Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 1993;91:1469-1480.
25. Clowes A, Reidy M, Clowes M. Kinetics of cellular proliferation after arterial injury, I: smooth muscle cell growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
26. Andrés V, Walsh K, Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis, J Cell Biol. 1996;132:657-666.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of baeteriophage T4. Nature (Lond). 1970;227:680-685.
28. Clowes AW, Clowes MM, Reidy MA, Kinetics of cellular proliferation after arterial injury. III: endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest. 1986;54:295-303.
29. Clowes AW, Schwartz SM, Significance of quiescent smooth muscle migration in the injured rat carotid artery. Cric Res. 1985;56:139-145.
30. Guo K, Wang J, Andrés V, Smith RC, Walsh K, MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995;15:3823-3829.
31. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB, Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995;267:1018-1021.
32. Cipl in muscle and other terminally differentiating cells. Science. 1995;267:1024-1027.
33. WAF1/Cipl expression in absence of p53. Oncogene. 1994; 9:3397-3406.
34. Zhang W, Grasso L, McClain CD, Oambel AM, Cha Y, Travail S, Deisseroth AB, Mercer WE. p53-independent induction of WAF1/Cipl in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 1995;55:668-674.
35. Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP, Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996;10:142-153.
36. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9:935-944.
37. WAF1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol. 1996;16:1335-1341.
38. Hall PA, Woods AL, Immunohistochemical markers of cell proliferation: achievements, problems and prospects, Cell Tissue Kinet. 1990;23:502-522.
39. Bravo R, Celis J. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol. 1980;84:795-802.
40. Bravo R. Synthesis of the nuclear protein (PCNA) and its relationships with DNA replication. Exp Cell Res. 1986;163:287-293.
41. Bravo R, MacDonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol. 1987;105:1549-1554.
42. Almendral J, Huebsch D, Blunclell P, MacDonald-Bravo H, Bravo R, Cloning and sequence of the human nuclear protein cyclin: homology with the DNA binding proteins, Proc Natl Acad Sci USA. 1987; 84:1575-1579.
43. Jaskulski D, Gatti C, Travali S, Calabretta B, Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem, 1988;263:10175-10179.
44. Belknap JK, Grieshsber NA, Schwartz PE, Orton EC, Reidy MA, Majaek RA. Tropoelastin gene expression in individual vascular smooth muscle cells: relationship to DNA synthesis during vascular development and after arterial injury. Circ Res. 1996;78:388-394.
45. Majesky MW, Schwartz SM, Clowes MM, Clowes AW, Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res. 1987;61:296-300.
46. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-555.
47. Sanders EJ, Varedi M, French AS, Cell proliferation in the gastrulating chick embryo: a study using BrdU incorporation and PCNA localization. Development. 1993;118:389-399.
48. Galand P, Degraef C. Cyclin/PCNA immunostatning as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet. 1989;22:383-392.
49. García R, Coltrera M, Gown A. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: comparison with flow cytometric analysis, Am J Pathol. 1989;134:733-739.
50. Hall P, Levison D, Woods A, Yu C-W, Kellock D, Watkins J, Barnes D, Gillet C, Camplejohn R, Waseem N, Lane D. Proliferating cell nuclear antigen (PCHA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. JPathol. 1990;162:285-294.
51. Kawakita N, Seki S, Sakaguchi S, Yanai A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am J Pathol. 1992;140:513-520.
52. Dou Q-P, Pardee AB, Keyomarsi K. Cyclin E: a better prognostic marker for breast cancer than cyclin D? Nat Med. 1996;2:254.
53. Dutta A, Chandra R, Leiter LM, Lester S, Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA. 1995;92:5386-5390.
54. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA. 1993;90:1112-1116.
55. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E. a potential prognostic marker for breast cancer. Cancer Res. 1994;54:380-385.
56. Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP. Deregulation of cyclin E in breast cancer. Oncogene. 1995;11:941-950.